ROP:SWX
Roche Holding AG Genussscheine
CHF 358.10
arrow_upward
+0.84%(+3.00) 1D
Jul 27, 11:06:48 AM GMT+2 · CHF
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ROP...
Open
CHF 358.90
High
CHF 361.00
Low
CHF 356.50
Mkt. cap
290.32B
Avg. vol.
1.02M
Volume
187.46K
Dividend
2.74%
Quarterly dividend
CHF 2.45
Ex-dividend date
Mar 27, 2025
P/E ratio
23.37
52-wk high
CHF 361.00
52-wk low
CHF 291.00
EPS
CHF 15.33
Shares outstanding
702.56M
No. of employees
113K
Open
CHF 358.90
High
CHF 361.00
Low
CHF 356.50
Mkt. cap
290.32B
Avg. vol.
1.02M
Volume
187.46K
Dividend
2.74%
Quarterly dividend
CHF 2.45
Ex-dividend date
Mar 27, 2025
P/E ratio
23.37
52-wk high
CHF 361.00
52-wk low
CHF 291.00
EPS
CHF 15.33
Shares outstanding
702.56M
No. of employees
113K
News stories
From sources across the web
Ad-hoc-news.de
·
4 hours ago
Roche stock trades steadily as diagnostics and pharma revenue support valuation
Ad-hoc-news.de
·
15 hours ago
Roche stock trades steady as oncology and immunology drive earnings momentum
AD HOC NEWS
·
22 hours ago
Roche Holding stock steadies as diagnostics strength offsets pharma headwinds
AD HOC NEWS
·
1 day ago
Roche stock gains as Hemlibra drives growth and pipeline stays broad
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG Genussscheine
CEOThomas Schinecker
Employees113K
FoundedOct 1, 1896
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websiteroche.com
AI content may include mistakes. Learn more